Ultrasound and diffuse optical tomography-transformer model for assessing pathological complete response to neoadjuvant chemotherapy in breast cancer

被引:2
作者
Zou, Yun [1 ]
Xue, Minghao [1 ]
Hossain, Md Iqbal [2 ]
Zhu, Quing [1 ,3 ]
机构
[1] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA
[2] Washington Univ, Imaging Sci, St Louis, MO USA
[3] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63130 USA
关键词
diffuse optical tomography; pathological complete response; dual input transformer; breast cancer; TUMOR RESPONSE; PREDICTION; ULTRASONOGRAPHY; ACCURACY; THERAPY; PET/CT;
D O I
10.1117/1.JBO.29.7.076007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Significance We evaluate the efficiency of integrating ultrasound (US) and diffuse optical tomography (DOT) images for predicting pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients. The ultrasound-diffuse optical tomography (USDOT)-Transformer model represents a significant step toward accurate prediction of pCR, which is critical for personalized treatment planning. Aim We aim to develop and assess the performance of the USDOT-Transformer model, which combines US and DOT images with tumor receptor biomarkers to predict the pCR of breast cancer patients under NAC. Approach We developed the USDOT-Transformer model using a dual-input transformer to process co-registered US and DOT images along with tumor receptor biomarkers. Our dataset comprised imaging data from 60 patients at multiple time points during their chemotherapy treatment. We used fivefold cross-validation to assess the model's performance, comparing its results against a single modality of US or DOT. Results The USDOT-Transformer model demonstrated excellent predictive performance, with a mean area under the receiving characteristic curve of 0.96 (95%CI: 0.93 to 0.99) across the fivefold cross-validation. The integration of US and DOT images significantly enhanced the model's ability to predict pCR, outperforming models that relied on a single imaging modality (0.87 for US and 0.82 for DOT). This performance indicates the potential of advanced deep learning techniques and multimodal imaging data for improving the accuracy (ACC) of pCR prediction. Conclusion The USDOT-Transformer model offers a promising non-invasive approach for predicting pCR to NAC in breast cancer patients. By leveraging the structural and functional information from US and DOT images, the model offers a faster and more reliable tool for personalized treatment planning. Future work will focus on expanding the dataset and refining the model to further improve its accuracy and generalizability.
引用
收藏
页数:15
相关论文
共 42 条
[11]   Deep Residual Learning for Image Recognition [J].
He, Kaiming ;
Zhang, Xiangyu ;
Ren, Shaoqing ;
Sun, Jian .
2016 IEEE CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION (CVPR), 2016, :770-778
[12]  
Henry EU, 2022, Arxiv, DOI [arXiv:2211.10043, DOI 10.48550/ARXIV.2211.10043]
[13]   A Comparison of Near-Infrared Diffuse Optical Imaging and 18F-FDG PET/CT for the Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy [J].
Jiang, Shudong ;
Pogue, Brian W. .
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) :1166-1167
[14]   Predicting Breast Tumor Response to Neoadjuvant Chemotherapy with Diffuse Optical Spectroscopic Tomography prior to Treatment [J].
Jiang, Shudong ;
Pogue, Brian W. ;
Kaufman, Peter A. ;
Gui, Jiang ;
Jermyn, Michael ;
Frazee, Tracy E. ;
Poplack, Steven P. ;
DiFlorio-Alexander, Roberta ;
Wells, Wendy A. ;
Paulsen, Keith D. .
CLINICAL CANCER RESEARCH, 2014, 20 (23) :6006-6015
[15]   Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer [J].
Joo, Sunghoon ;
Ko, Eun Sook ;
Kwon, Soonhwan ;
Jeon, Eunjoo ;
Jung, Hyungsik ;
Kim, Ji-Yeon ;
Chung, Myung Jin ;
Im, Young-Hyuck .
SCIENTIFIC REPORTS, 2021, 11 (01)
[16]   Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer [J].
Keune, Jason D. ;
Jeffe, Donna B. ;
Schootman, Mario ;
Hoffman, Abigail ;
Gillanders, William E. ;
Aft, Rebecca L. .
AMERICAN JOURNAL OF SURGERY, 2010, 199 (04) :477-484
[17]   Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer [J].
Li, Fengling ;
Yang, Yongquan ;
Wei, Yani ;
He, Ping ;
Chen, Jie ;
Zheng, Zhongxi ;
Bu, Hong .
JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
[18]   Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study [J].
Liu, Zhenyu ;
Li, Zhuolin ;
Qu, Jinrong ;
Zhang, Renzhi ;
Zhou, Xuezhi ;
Li, Longfei ;
Sun, Kai ;
Tang, Zhenchao ;
Jiang, Hui ;
Li, Hailiang ;
Xiong, Qianqian ;
Ding, Yingying ;
Zhao, Xinming ;
Wang, Kun ;
Liu, Zaiyi ;
Tian, Jie .
CLINICAL CANCER RESEARCH, 2019, 25 (12) :3538-3547
[19]   Preoperative (neoadjuvant) chemotherapy in patients with breast cancer [J].
Mamounas, EP ;
Fisher, B .
SEMINARS IN ONCOLOGY, 2001, 28 (04) :389-399
[20]   Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer [J].
Marinovich, Michael Luke ;
Houssami, Nehmat ;
Macaskill, Petra ;
von Minckwitz, Gunter ;
Blohmer, Jens-Uwe ;
Irwig, Les .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (11) :2730-2737